DOSIMETRY AND RADIATION PROTECTION IN CF-252 BRACHYTHERAPY PROGRAM

被引:0
|
作者
ANDERSON, LL
机构
来源
PHYSICS IN MEDICINE AND BIOLOGY | 1972年 / 17卷 / 05期
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
引用
收藏
页码:682 / &
相关论文
共 50 条
  • [41] CF-252 AS A NEUTRON SOURCE
    HOHLEIN, G
    ATOMWIRTSCHAFT, 1970, 15 (11): : 514 - &
  • [42] SOME CHARACTERISTICS OF GAMMA RADIATION ACCOMPANYING FISSION OF CF-252
    VALSKII, GV
    ALEKSAND.BM
    BARANOV, IA
    KRIVOKHA.AS
    PETROV, GA
    PLEVA, YS
    SOVIET JOURNAL OF NUCLEAR PHYSICS-USSR, 1970, 10 (02): : 137 - &
  • [43] CELLULAR EFFECTS OF CF-252 RADIATION IN HELA MR CELLS
    BAN, S
    IIDA, S
    AWA, AA
    JOURNAL OF RADIATION RESEARCH, 1987, 28 (01) : 38 - 38
  • [44] SPERM SHAPE ABNORMALITIES IN MICE EXPOSED TO CF-252 RADIATION
    GOUD, SN
    FEOLA, JM
    MARUYMA, Y
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1987, 52 (05) : 755 - 760
  • [45] Radiotherapy coupling boron neutron capture therapy (BNCT) and Cf-252 of brachytherapy
    Chaves, IE
    Campos, TPR
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 197 - 197
  • [46] Neutron Energy and Dose Considerations of Cf-252 Brachytherapy Sources for Various Geometries
    Giantsoudi, D.
    Liu, Y.
    Diaz, A.
    Mavroidis, P.
    Papanikolaou, N.
    MEDICAL PHYSICS, 2008, 35 (06)
  • [47] CF-252 HAZARD DEMONSTRATED
    ROBERTS, TC
    INDUSTRIAL RESEARCH, 1977, 19 (02): : 142 - 142
  • [48] SCALP NECROSIS DURING CF-252 NEUTRON BRACHYTHERAPY FOR GLIOBLASTOMA-MULTIFORME
    CIUBA, D
    YAES, RJ
    MILLER, JP
    YOUNG, AB
    PATCHELL, R
    MARUYAMA, Y
    RADIOLOGY, 1992, 185 : 326 - 326
  • [49] INVESTIGATIONS OF THE HARD BETA RADIATION FROM CF-252 FISSION
    BOROVOY, AA
    KLIMOV, YV
    KOPEYKIN, VI
    SHKOLNIK, KD
    JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS, 1979, 5 (05) : 723 - 731
  • [50] HYPERTHERMIA AND CF-252 NEUTRON BRACHYTHERAPY FOR CONTROL OF BULKY SURFACE HUMAN NEOPLASMS
    MARUYAMA, Y
    NELSON, O
    LUCE, E
    WILLS, C
    BEACH, JL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 198 - 198